Austin, United States
Emerald Cloud Lab (ECL), founded in 2010, is advancing the field of Biotechnology with its revolutionary approach to scientific research. It offers a unique platform where experiments are conducted in a programmable research laboratory, giving scientists global access to execute their research 24/7, all year round.
The lab’s cutting-edge infrastructure is managed through a unified software interface that streamlines every step of the scientific process from design to analysis. This innovative model not only enhances productivity and accuracy but also reduces operational costs and minimizes environmental impact.
Headquartered in the United States, ECL has attracted the attention of notable investors such as Alcazar Energy Partners and Alumni Ventures, with the last known investment occurring on April 1, 2019. This indicates significant market confidence and potential for future scalability in the thriving biotech landscape.
